Zymeworks (ZYME) Other Working Capital Changes (2021 - 2026)
Zymeworks recorded quarterly Other Working Capital Changes of -$1.0 million in Q1 2026, up 95.14% quarter-over-quarter from -$20.7 million in Q4 2025, and up 65.01% year-over-year from -$609065.2 in Q1 2025.
Zymeworks' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 65.01% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$21.3 million (down 94.98% YoY), while the FY2025 annual figure was -$23.2 million, down 178.72% from the prior year.
- Other Working Capital Changes came in at -$1.0 million for Q1 2026 at Zymeworks, up from -$20.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $19.3 million in Q3 2025 to a low of -$20.7 million in Q4 2025.
- A 5-year average of -$1.6 million and a median of -$732000.0 in 2024 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 2732.92% in 2025 and fell as far as 2542.71% in 2025.
- Zymeworks' Other Working Capital Changes stood at $642000.0 in 2022, then soared by 2341.59% to $15.7 million in 2023, then plunged by 104.99% to -$782000.0 in 2024, then slumped by 2542.71% to -$20.7 million in 2025, then surged by 95.14% to -$1.0 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.0 million, -$20.7 million, and $19.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -20.67 Mn |
| Dec 31, 2025 | -20.67 Mn |
| Sep 30, 2025 | 19.27 Mn |
| Sep 30, 2025 | 19.27 Mn |
| Jun 30, 2025 | -18.91 Mn |
| Jun 30, 2025 | -18.91 Mn |
| Mar 31, 2025 | -2.87 Mn |
| Mar 31, 2025 | -2.87 Mn |
| Dec 31, 2024 | -782,000.00 |
| Dec 31, 2024 | -782,000.00 |
| Sep 30, 2024 | -732,000.00 |
| Sep 30, 2024 | -732,000.00 |
| Jun 30, 2024 | -6.54 Mn |
| Jun 30, 2024 | -6.54 Mn |
| Mar 31, 2024 | -259,000.00 |
| Mar 31, 2024 | -259,000.00 |
| Dec 31, 2023 | 15.68 Mn |
| Dec 31, 2023 | 15.68 Mn |
| Sep 30, 2023 | -17.98 Mn |
| Sep 30, 2023 | -17.98 Mn |
| Jun 30, 2023 | 6.82 Mn |
| Jun 30, 2023 | 6.82 Mn |
| Mar 31, 2023 | -820,000.00 |
| Mar 31, 2023 | -820,000.00 |
| Dec 31, 2022 | 642,000.00 |
| Dec 31, 2022 | 642,000.00 |
| Sep 30, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 750,000.00 |
| Mar 31, 2022 | -648,000.00 |
| Mar 31, 2022 | -648,000.00 |
| Dec 31, 2021 | -11.61 Mn |
| Dec 31, 2021 | -11.61 Mn |